 | Ginkgo Bioworks Holdings, Inc. | |||
| NYQ : DNA || Location: United States | ||||
$0.76-0.08 (-9.94%) |
26.01 M | 0.74 - 0.82 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 266.527 M |
| March 28, 2024 | 270.826 M |
| March 15, 2024 | 262.237 M |
| Feb. 29, 2024 | 255.717 M |
| Feb. 15, 2024 | 250.235 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.10 | -0.11 | -12.70% |
| 09/30/2023 | -0.09 | -0.16 | -84.76% |
| 06/30/2023 | -0.09 | -0.09 | -5.76% |
| 03/31/2023 | -0.09 | -0.11 | -21.01% |
| 12/31/2022 | -0.21 | -0.09 | 57.29% |
DNA Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 1650.910M | Shares Float | 1116.293M |
| Short Float | 266.527M | Market Cap | 1403.27M |
| Institution ownership | 83.30% | Insider ownership | 6.740% |
| Earnings Date | 05/13/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.46 | Forward EPS | -0.27 |